See also this year's filing and all EDGAR filings for this company.
PDF Report 0001349929_2017_Vyant_Bio_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Assets', 'missing_ratio': 0.2516841251366698, 'aggregate_val': 42434000, 'exp_sum': 56706000, 'exp_to_value': {'IntangibleAssets': 12029000, 'AssetsNonCurrent': 14272000, 'AssetsCurrent': 23424000, 'PropertyPlantAndEquipment': 4738000, 'remainder_Assets': 2243000}} |
Graph
Absolute values for 0001349929, Vyant Bio Inc.
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 12,029,000 |
| 1 | AssetsNonCurrent | 14,272,000 |
| 2 | AssetsCurrent | 23,424,000 |
| 3 | PropertyPlantAndEquipment | 4,738,000 |
| 4 | remainder_Assets | -12,029,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 11,046,000 |
| 7 | remainder_Liabilities | 5,764,000 |
| 8 | LaborExpense | 0 |
| 9 | CostOfGoodsAndServicesSold | 17,104,000 |
| 10 | GeneralAndAdministrativeExpense | 16,034,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 0 |
| 13 | DepreciationDepletionAndAmortization | 0 |
| 14 | SellingAndMarketingExpense | 4,668,000 |
| 15 | ResearchAndDevelopmentExpense | 5,967,000 |
| 16 | remainder_Expenses | 0 |
| 17 | remainder_Revenues | 27,049,000 |
| 18 | remainder_NetIncome | 921,000 |
| 19 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 42,434,000 |
| 1 | Liabilities | 16,810,000 |
| 2 | Expenses | 43,773,000 |
| 3 | Revenues | 27,049,000 |
| 4 | StockholdersEquity | 25,624,000 |
| 5 | NetIncome | -15,803,000 |
| 6 | ComprehensiveNetIncome | -15,803,000 |
| 7 | BaseVar | 77,331,095 |
| 8 | EconomicCapitalRatio | 0.752 |
Edgar->Model Mapping
Feature Distribution
